54 Drugs are under Development by America’s Biopharmaceutical Research Companies

According to news released by the Pharmaceutical Research and Manufacturers of America (PhRMA), America’s Biopharmaceutical Research Companies started researching and development on 54 medicines find the medicine that can treat Chronic Obstructive Pulmonary Disease (COPD).

These medicines are in late-stage development, means they are either in clinical trials or perhaps waiting for the approval of Food and Drug Administration (FDA).

In America, more than 13 million adults suffering from Chronic Obstructive Pulmonary Diseases (COPD) that is one of the common lung diseases in the U.S. A. This disease will lower the respiratory system that encompasses two main conditions, like chronic bronchitis and emphysema.

The person who is suffering from COPD has obstructed airflow to the lungs that do not allow normal breathing. The people affected by COPD have limited ability to work, exercise and perform daily activities.

PhRMA president and CEO John J. Castellani said, “Detecting COPD in early stage is very important, as effective treatment can change the course and can bring out from this dangerous disease.” In U.S, more than 120,000 die from this COPD annually, and it is the third leading cause of the individual’s death in America.